Coracten is usually a dihydropyridine calcium-channel blocker and is particularly contraindicated in patients with recognised major dihydropyridine hypersensitivity.Nifedipine can be used together with beta-blocking medication along with other antihypertensive agents, but the potential for an additive influence leading to postural hypotension ought